(Q44632015)

4 December 2017

title

Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010. (English)

1 reference

4 December 2017

Christoph Gensch

1

1 reference

4 December 2017

Uta Hoppe

series ordinal

2

1 reference

4 December 2017

Michael Böhm

series ordinal

3

1 reference

4 December 2017

Ulrich Laufs

series ordinal

4

1 reference

4 December 2017

language of work or name

1 reference

23 December 2010

1 reference

Clinical Research in Cardiology

4 December 2017

published in

1 reference

4 December 2017

volume

100

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

1-9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-010-0270-3

4 December 2017

exact match

0 references

cites work

Clinical trial updates and hotline sessions presented at the Scientific Session 2007 of the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0270-3

Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0270-3

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0270-3

HDL and CETP in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0270-3

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0270-3

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0270-3

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0270-3

Hypertension treatment and control in five European countries, Canada, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0270-3

Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrio

21 January 2018

1 reference

12 December 2020

Cardiac-resynchronization therapy for mild-to-moderate heart failure

1 reference

12 December 2020

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

1 reference

12 December 2020

Telemonitoring in patients with heart failure

1 reference

12 December 2020

Study Design of the CLOSURE I Trial

1 reference

12 December 2020

Neural control of renal function

1 reference

12 December 2020

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

1 reference

12 December 2020

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial

1 reference

12 December 2020

Safety of anacetrapib in patients with or at high risk for coronary heart disease

1 reference

12 December 2020

[Summary of the article: Zannad F, McMurray JJV, Krum H et al.; for the EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med, 2011; 364: 11-21]

1 reference

12 December 2020

10.1007/S00392-010-0270-3

Identifiers

DOI

1 reference

4 December 2017

1 reference